154 related articles for article (PubMed ID: 29605500)
1. Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study.
Bonhof CS; Mols F; Vos MC; Pijnenborg JMA; Boll D; Vreugdenhil G; Ezendam NPM; van de Poll-Franse LV
Gynecol Oncol; 2018 Jun; 149(3):455-463. PubMed ID: 29605500
[TBL] [Abstract][Full Text] [Related]
2. The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.
Bonhof CS; van de Poll-Franse LV; Wasowicz DK; Beerepoot LV; Vreugdenhil G; Mols F
J Cancer Surviv; 2021 Apr; 15(2):190-200. PubMed ID: 33185839
[TBL] [Abstract][Full Text] [Related]
3. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry.
Ezendam NP; Pijlman B; Bhugwandass C; Pruijt JF; Mols F; Vos MC; Pijnenborg JM; van de Poll-Franse LV
Gynecol Oncol; 2014 Dec; 135(3):510-7. PubMed ID: 25281491
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
[TBL] [Abstract][Full Text] [Related]
6. Symptoms of pre-treatment anxiety are associated with the development of chronic peripheral neuropathy among colorectal cancer patients.
Bonhof CS; van de Graaf DL; Wasowicz DK; Vreugdenhil G; Mols F
Support Care Cancer; 2022 Jun; 30(6):5421-5429. PubMed ID: 35303166
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
Jin L; Zhang Y; Yang W
Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
[TBL] [Abstract][Full Text] [Related]
8. Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy.
Trompetter HR; Bonhof CS; van de Poll-Franse LV; Vreugdenhil G; Mols F
Support Care Cancer; 2022 Jan; 30(1):95-104. PubMed ID: 34232392
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
Cheng HL; Molassiotis A
Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.
Mols F; Beijers AJ; Vreugdenhil G; Verhulst A; Schep G; Husson O
J Cancer Surviv; 2015 Sep; 9(3):512-22. PubMed ID: 25876556
[TBL] [Abstract][Full Text] [Related]
11. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population.
Mols F; van de Poll-Franse LV; Vreugdenhil G; Beijers AJ; Kieffer JM; Aaronson NK; Husson O
Eur J Cancer; 2016 Dec; 69():28-38. PubMed ID: 27814471
[TBL] [Abstract][Full Text] [Related]
12. Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.
Bonhof CS; van de Poll-Franse LV; de Hingh IH; Vreugdenhil G; Mols F
Support Care Cancer; 2022 Nov; 30(11):9517-9526. PubMed ID: 36030458
[TBL] [Abstract][Full Text] [Related]
13. Association between peripheral neuropathy and sleep quality among colorectal cancer patients from diagnosis until 2-year follow-up: results from the PROFILES registry.
Bonhof CS; Van de Poll-Franse LV; de Hingh IH; Nefs G; Vreugdenhil G; Mols F
J Cancer Surviv; 2023 Jun; 17(3):894-905. PubMed ID: 34799785
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.
Simon NB; Danso MA; Alberico TA; Basch E; Bennett AV
Qual Life Res; 2017 Oct; 26(10):2763-2772. PubMed ID: 28664460
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
[TBL] [Abstract][Full Text] [Related]
16. Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study.
Tabata A; Kanai M; Horimatsu T; Tsuboyama T; Matsushima K; Kato T
Support Care Cancer; 2018 Jul; 26(7):2397-2405. PubMed ID: 29423680
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-Induced Peripheral Neuropathy (CIPN) as a Predictor of Decreased Quality of Life in Testicular Germ Cell Tumor Survivors.
Orszaghova Z; Galikova D; Lesko P; Obertova J; Rejlekova K; Sycova-Mila Z; Palacka P; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M; Chovanec M
Clin Genitourin Cancer; 2024 Jun; 22(3):102067. PubMed ID: 38555680
[TBL] [Abstract][Full Text] [Related]
18. Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: a longitudinal analysis.
Zandbergen N; de Rooij BH; Vos MC; Pijnenborg JMA; Boll D; Kruitwagen RFPM; van de Poll-Franse LV; Ezendam NPM
Acta Oncol; 2019 May; 58(5):790-800. PubMed ID: 30698069
[No Abstract] [Full Text] [Related]
19. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Lin KY; Chen PS; Lin CF
BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
[TBL] [Abstract][Full Text] [Related]
20. Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trial.
Streckmann F; Lehmann HC; Balke M; Schenk A; Oberste M; Heller A; Schürhörster A; Elter T; Bloch W; Baumann FT
Support Care Cancer; 2019 Jul; 27(7):2471-2478. PubMed ID: 30382392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
